Johnson & Johnson is on Fairygodboss’ Best Companies for Women of 2020.
Fairygodboss members gave this company a 4.2/5 in overall job satisfaction
Fairygodboss members working at Johnson & Johnson rated their manager’s support a 4.3/5
Reviewers say women are treated fairly and equally to men
Reviewers would recommend company to other women
Reviewers say the CEO supports gender diversity
Global parental leave for all new parents (maternal, paternal, adoptive or surrogacy-assisted).
Global exercise reimbursement.
Two weeks off (one of them fully paid) for volunteer work.
#2105970883W
Janssen Research & Development, L.L.C., a member of Johnson & Johnson's Family of Companies, is recruiting for a Director, North America/Global Regulatory Leader. The position will preferably be based in Spring House, PA, but flexible arrangements for other site locations can be negotiated. At the Janssen Pharmaceutical Companies of Johnson & Johnson, we are working to create a world without disease. Transforming lives by finding new and better ways to prevent, intercept, treat and cure disease inspires us. We bring together the best minds and pursue the most promising science. We are Janssen. We collaborate with the world for the health of everyone in it. Learn more at www.janssen.com and follow us @JanssenGlobal. Janssen Research & Development, LLC, is part of the Janssen Pharmaceutical Companies. Role Summary The Director, North American/Global Regulatory Leader, Immunology will be responsible for the development, implementation and maintenance of North American regulatory strategies for both large and small molecules with indications targeted in areas of Rheumatology, Gastroenterology, and Dermatology. In addition, the director will also be responsible for global regulatory strategies for select large and small molecule projects spanning the same target disease areas. The Director, North America/Global Regulatory Leader (NA/GRL), Immunology will: Be responsible for the development, implementation and maintenance of robust North American/Global regulatory strategies for both large and small molecules with indications targeted in areas of Rheumatology, Gastroenterology, and Dermatology, and rare diseases. Be a key contributor/leader on the Global Regulatory Team and on multiple cross-functional teams including but not limited to the Global Dossier Team, Clinical Working Group, the Labeling Working Group, and the Compound Development Team. Provide strategic direction to the teams and critical review of key Health Authority submissions such as IND/CTAs, meeting requests, briefing documents, response documents and marketing and supplemental applications. Scope of contribution (e.g., regional or global) will be dependent on role on program. Assure that regulatory strategies throughout life cycle of compounds are in alignment with Immunology portfolio, regional strategies, CMC-Regulatory Affairs strategy, commercial and market access strategy, and the Target Product Profile (for global programs as assigned). In interacting with the Health Authorities, the NA/GRL will lead and/or participate in meetings with FDA, Health Canada and other Health Authorities (HAs) as appropriate. Preparing company personnel and developing contingency strategies for interactions with HAs. Interacting with operating companies and development partners. In NARL role, establish North American content requirements and timing for global dossier plans including BLA/NDAs, IND/CTAs as well as addendums & supplements. In NARL role, lead the regulatory response team for FDA and Health Canada questions. In GRL role, provide integrated global labeling and filing strategy for assigned projects In NARL role, manage routine maintenance submissions, manage & track NA post-approval commitments, provide input and review submission documents, as well as approves submissions before dispatching to regulatory authorities. As the GRL, serve as a member of LWG to create or update the CCDS and contributes to the development of local labels as appropriate. In the NARL role, contributes to the development of the USPI, lead the development of NA labelling negotiation strategies, and development of supporting documentation for labelling, as well as reviews FDA and Health Canada labelling to ensure consistency with the CCDS and ensure that annotations are complete and correct. Provides regulatory input to clinical development programs, risk/benefit assessments, medical affairs programs and for the target label. Qualifications A minimum of bachelor’s degree is required. A degree in a scientific discipline is strongly preferred. An advanced degree (MS, PhD, MD or Pharm D) is strongly preferred. 10 + years of pharmaceutical industry or health authority experience is required. A minimum of 6 years of RA or related experience is required. Experience leading interactions with Health Authorities is required. Global regulatory experience is strongly preferred. A broad understanding and experience in drug development including early and late development is highly preferred. A broad understanding of lifecycle management is required. Ability to interpret and understand regulatory requirements/precedent in the context of the scientific and commercial environment is required. Previous experience in the Immunology therapeutic area or with rare diseases is highly preferred Deep knowledge of FDA is required, and Health Canada regulations and guidelines related to the product/project life cycle is preferred. Working knowledge of US labelling requirements is required Knowledge of FDA structures & how that Agency operates; knowledge & understanding of commercial business needs; and understanding of scientific data (clinical & non-clinical) is required. Ability to work successfully in a matrixed environment as a leader and individual contributor Project management skills, strong oral & written communication skills and organization & multi-tasking skills are required. The position will preferably be based in Spring House, PA, but flexible arrangements for other site locations can be negotiated. Will be required to travel up to 10% domestic and internationally. Johnson & Johnson is an Affirmative Action and Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, age, national origin, or protected veteran status and will not be discriminated against on the basis of disability. Primary Location United States-Pennsylvania-Spring House-Welsh & McKean Roads Other Locations North America-United States Organization Janssen Research & Development, LLC (6084) Job Function Regulatory Affairs Requisition ID 2105970883W
Child care benefits
Paid maternity
Unpaid maternity
Paid paternity
Unpaid paternity
Paid adoptive
Short term disability
Johnson & Johnson is on Fairygodboss’ Best Companies for Women of 2020.
Fairygodboss members gave this company a 4.2/5 in overall job satisfaction
Fairygodboss members working at Johnson & Johnson rated their manager’s support a 4.3/5
Reviewers say women are treated fairly and equally to men
Reviewers would recommend company to other women
Reviewers say the CEO supports gender diversity
Global parental leave for all new parents (maternal, paternal, adoptive or surrogacy-assisted).
Global exercise reimbursement.
Two weeks off (one of them fully paid) for volunteer work.